<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d8">
    <sentence id="DDI-MedLine.d8.s0" text="In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans.&#xa;">
        <entity id="DDI-MedLine.d8.s0.e0" charOffset="21-28"
            type="drug_n" text="KRM-1648"/>
        <entity id="DDI-MedLine.d8.s0.e1" charOffset="68-76" type="drug" text="ofloxacin"/>
        <pair id="DDI-MedLine.d8.s0.p0" e1="DDI-MedLine.d8.s0.e0"
            e2="DDI-MedLine.d8.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s1" text="The antimicrobial effect of a benzoxazinorifamycin, KRM-1648, either alone or in combination with ofloxacin, was evaluated in vitro against two type strains and six clinical isolates of Mycobacterium ulcerans. ">
        <entity id="DDI-MedLine.d8.s1.e0" charOffset="30-49"
            type="drug_n" text="benzoxazinorifamycin"/>
        <entity id="DDI-MedLine.d8.s1.e1" charOffset="52-59"
            type="drug_n" text="KRM-1648"/>
        <entity id="DDI-MedLine.d8.s1.e2" charOffset="98-106"
            type="drug" text="ofloxacin"/>
        <pair id="DDI-MedLine.d8.s1.p0" e1="DDI-MedLine.d8.s1.e0"
            e2="DDI-MedLine.d8.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d8.s1.p1" e1="DDI-MedLine.d8.s1.e0"
            e2="DDI-MedLine.d8.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d8.s1.p2" e1="DDI-MedLine.d8.s1.e1"
            e2="DDI-MedLine.d8.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s2" text="Growth of M. "/>
    <sentence id="DDI-MedLine.d8.s3" text="ulcerans was measured by plate counts and the BACTEC radiometric method. "/>
    <sentence id="DDI-MedLine.d8.s4" text="The minimal inhibitory concentration as well as minimal bactericidal concentration of KRM-1648 against M. ">
        <entity id="DDI-MedLine.d8.s4.e0" charOffset="86-93"
            type="drug_n" text="KRM-1648"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s5" text="ulcerans was between 0.012 and 0.025 mg/l, while corresponding values for rifampicin and rifabutin were in the range of 0.1-0.8 mg/l and 0.1-0.4 mg/l respectively. ">
        <entity id="DDI-MedLine.d8.s5.e0" charOffset="74-83" type="drug" text="rifampicin"/>
        <entity id="DDI-MedLine.d8.s5.e1" charOffset="89-97" type="drug" text="rifabutin"/>
        <pair id="DDI-MedLine.d8.s5.p0" e1="DDI-MedLine.d8.s5.e0"
            e2="DDI-MedLine.d8.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s6" text="When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. ">
        <entity id="DDI-MedLine.d8.s6.e0" charOffset="19-27" type="drug" text="ofloxacin"/>
        <entity id="DDI-MedLine.d8.s6.e1" charOffset="30-37"
            type="drug_n" text="KRM-1648"/>
        <entity id="DDI-MedLine.d8.s6.e2" charOffset="143-152"
            type="drug" text="rifampicin"/>
        <entity id="DDI-MedLine.d8.s6.e3" charOffset="158-166"
            type="drug" text="rifabutin"/>
        <entity id="DDI-MedLine.d8.s6.e4" charOffset="173-181"
            type="drug" text="ofloxacin"/>
        <pair id="DDI-MedLine.d8.s6.p0" e1="DDI-MedLine.d8.s6.e0"
            e2="DDI-MedLine.d8.s6.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d8.s6.p1" e1="DDI-MedLine.d8.s6.e0"
            e2="DDI-MedLine.d8.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p2" e1="DDI-MedLine.d8.s6.e0"
            e2="DDI-MedLine.d8.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p3" e1="DDI-MedLine.d8.s6.e0"
            e2="DDI-MedLine.d8.s6.e4" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p4" e1="DDI-MedLine.d8.s6.e1"
            e2="DDI-MedLine.d8.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p5" e1="DDI-MedLine.d8.s6.e1"
            e2="DDI-MedLine.d8.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p6" e1="DDI-MedLine.d8.s6.e1"
            e2="DDI-MedLine.d8.s6.e4" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p7" e1="DDI-MedLine.d8.s6.e2"
            e2="DDI-MedLine.d8.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d8.s6.p8" e1="DDI-MedLine.d8.s6.e2"
            e2="DDI-MedLine.d8.s6.e4" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d8.s6.p9" e1="DDI-MedLine.d8.s6.e3"
            e2="DDI-MedLine.d8.s6.e4" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s7" text="These results suggest that KRM-1648 has a great potential in the treatment of M. ">
        <entity id="DDI-MedLine.d8.s7.e0" charOffset="27-34"
            type="drug_n" text="KRM-1648"/>
    </sentence>
    <sentence id="DDI-MedLine.d8.s8" text="ulcerans infection."/>
</document>
